Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Cancer Discovery|December 25, 2015
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor ProgressionGuocan Wang, Xin Lu, Prasenjit Dey, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Cancer Letters|November 30, 2025
KDM4A promotes NEPC progression through regulation of MYC expressionCelia Sze Ling Mak, Ming Zhu, Jie Fu, et al.
Nature Communications|April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancersOmar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2022
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard scoreMinh-Phuong Huynh-Le, Roshan Karunamuni, Chun Chieh Fan, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Cancer Discovery|December 25, 2015
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor ProgressionGuocan Wang, Xin Lu, Prasenjit Dey, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Cancer Letters|November 30, 2025
KDM4A promotes NEPC progression through regulation of MYC expressionCelia Sze Ling Mak, Ming Zhu, Jie Fu, et al.
Nature Communications|April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancersOmar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2022
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard scoreMinh-Phuong Huynh-Le, Roshan Karunamuni, Chun Chieh Fan, et al.
Pageof 26